Monthly information on share capital and company voting rights

On July 5, 2024, Cellectis provided an update on its share capital and voting rights as required by Article 223-16 of the French financial markets authority.

Rhea-AI Summary

On July 5, 2024, Cellectis provided an update on its share capital and voting rights as required by Article 223-16 of the French financial markets authority.

The company, listed on the Euronext Growth market under ISIN code FR0010425595, reported a total of 100,093,635 shares in its capital as of June 30, 2024.

The total number of voting rights for the same period was 88,029,364.

For any queries, media can contact Pascalyne Wilson, Director of Communications, or Patricia Sosa Navarro, Chief of Staff to the CEO. Investor relations are managed by Arthur Stril, Interim CFO, and Ashley R. Robinson from LifeSci Advisors.

Argus Session date unavailable

-0.98% session move Open Argus

Details

News Market Reaction – CLLS

The recorded move for CLLS in the trading session of this news was -0.98%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, July 05, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
06/30/2024	100,093,635	88,029,364

For further information on Cellectis, please contact:     

Media contact:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contacts:

Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com

Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577

 

Attachment

• Voting_Rights_PR_June2024_EN.pdf

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the total number of shares in Cellectis' capital as of June 30, 2024?

As of June 30, 2024, Cellectis' total number of shares in the capital was 100,093,635.

How many voting rights does Cellectis have as of June 30, 2024?

Cellectis had a total of 88,029,364 voting rights as of June 30, 2024.

On which market is Cellectis listed?

Cellectis is listed on the Euronext Growth market.

What is the ISIN code for Cellectis?

The ISIN code for Cellectis is FR0010425595.

Who should be contacted for media inquiries regarding Cellectis?

For media inquiries, contact Pascalyne Wilson, Director of Communications, or Patricia Sosa Navarro, Chief of Staff to the CEO.